Evommune EVMN Derivative Liability Upon Conversions Of Preferred Shares
Derivative Liability Upon Conversions Of Preferred Shares at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:DerivativeLiabilityUponConversionsOfPreferredShares.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's derivative liability upon conversions of preferred shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's derivative liability upon conversions of preferred shares?
- Evommune (EVMN) reported derivative liability upon conversions of preferred shares of -$5.11K in Q1 2026.
- How has Evommune 's derivative liability upon conversions of preferred shares changed year-over-year?
- Evommune 's derivative liability upon conversions of preferred shares increased by 98.4% year-over-year, from -$313.2K to -$5.11K.
- What does derivative liability upon conversions of preferred shares mean?
- Captures the change in derivative liability valuation specifically triggered by the conversion of preferred equity into common stock. It highlights the impact of capital structure changes on the company's balance sheet obligations.